Palmoplantar Pustulosis Market Size, Share, Trends, Growth, Key Companies, Emerging Drugs and Epidemiology Forecast by DelveInsight

Palmoplantar Pustulosis Market Size, Share, Trends, Growth, Key Companies, Emerging Drugs and Epidemiology Forecast by DelveInsight

Palmoplantar Pustulosis Market


Palmoplantar pustulosis (PPP) is an uncommon chronic pustular condition affecting the palms and soles. Blisters and fluid-filled bumps known as pustules appear on the palms of the hands and the soles of the feet. It is a rare autoimmune condition and is more likely to affect people who currently or used to smoke. It is related to a common skin condition, psoriasis.

PPP can be diagnosed by examining the affected skin and skin swabs. In some patients, a skin biopsy might also be required. There is currently no definitive cure for Palmoplantar Pustulosis (PPP) but there are different treatment options available like Topical steroids, Emollients, Retinoid medications, phototherapy or ultraviolet light therapy, tar ointments, immunosuppressive therapy, and others.


Get FREE sample copy at:


DelveInsight’s “Palmoplantar Pustulosis (PPP) Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the Palmoplantar Pustulosis (PPP), historical and forecasted epidemiology as well as the Palmoplantar Pustulosis (PPP) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Palmoplantar Pustulosis (PPP) market report also covers emerging drugs, current treatment practices, Palmoplantar Pustulosis market size and share of the individual therapies, current and forecasted Palmoplantar Pustulosis (PPP) Market Size from 2017 to 2030 segmented by seven major markets. The report provides a detailed current Palmoplantar Pustulosis (PPP) treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market. 



Palmoplantar Pustulosis (PPP) Market Key Facts

  • Psoriatic nail involvement is frequently seen in Palmoplantar Pustulosis (PPP) and a family history of psoriasis has also been recorded in 10-42% of patients affected by PPP.
  • As per a study conducted by Miceli and Schmieder (2020) titled “Palmoplantar Psoriasis”, Palmoplantar Pustulosis (PPP) has an average age of onset between 20 and 60 years of age and shows a clear predilection for females, with a female-to-male ratio of 8:2.


Key Benefits of Palmoplantar Pustulosis (PPP) Market Report

  • Palmoplantar Pustulosis (PPP) market report provides an in-depth analysis of Palmoplantar Pustulosis (PPP) Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major markets i.e. EU5 (Germany, Italy, Spain, France and the UK), Japan, and the United States.
  • The Palmoplantar Pustulosis (PPP) market report will help in developing business strategies by understanding the Palmoplantar Pustulosis (PPP) Market trends & developments, key players, and future market competition that will shape and drive the Palmoplantar Pustulosis (PPP) market in the upcoming years.
  • The Palmoplantar Pustulosis (PPP) market report covers Palmoplantar Pustulosis (PPP) market growth and current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.
  • The report provides a detailed assessment of the Palmoplantar Pustulosis (PPP) patient populationmarket drivers & barriers, Unmet Needs, market opportunities, comparative analysis of pipeline products with detailed clinical profiles, and other factors. 


Palmoplantar Pustulosis Market

The Palmoplantar Pustulosis (PPP) market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Palmoplantar Pustulosis (PPP) market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers, and demand for better technology. 

The report gives a thorough detail of Palmoplantar Pustulosis (PPP) market trends and shares analysis of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders. 


Get FREE sample copy at:


Palmoplantar Pustulosis (PPP) Epidemiology

The Palmoplantar Pustulosis (PPP) epidemiology section covers insights about historical and current Palmoplantar Pustulosis (PPP) patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.

It helps to recognize the causes of current and forecasted Palmoplantar Pustulosis (PPP) epidemiology trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

Palmoplantar Pustulosis (PPP) Drugs Uptake and Key Market Players

The Palmoplantar Pustulosis (PPP) Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Palmoplantar Pustulosis (PPP) market or expected to get launched in the market during the study period. The analysis covers Palmoplantar Pustulosis (PPP) market uptake by drugs; patient uptake by therapies; and sales of each drug.    

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The pipeline of Palmoplantar Pustulosis (PPP) possesses several mid and late-phase potential key players, Palmoplantar Pustulosis (PPP) market size is anticipated to change in the coming years owing to the improvement in the research and development activities so that market will comprise of efficient treatment options. The launch of emerging therapies is expected during the forecast period.


Get FREE sample copy at:


Palmoplantar Pustulosis (PPP) Companies:
Kyowa Kirin
Boehringer Ingelheim
And many others.


Palmoplantar Pustulosis (PPP) Therapies covered in the report include:
And many more.


Table of Content

  1. Key Insights
  2. Executive Summary 
  3. Palmoplantar Pustulosis (PPP) Competitive Intelligence Analysis
  4. Palmoplantar Pustulosis (PPP) Market Overview at a Glance
  5. Palmoplantar Pustulosis (PPP) Disease Background and Overview
  6. Palmoplantar Pustulosis (PPP) Patient Journey
  7. Palmoplantar Pustulosis (PPP) Epidemiology and Patient Population
  8. Palmoplantar Pustulosis (PPP) Treatment Algorithm, Current Treatment, and Medical Practices
  9. Palmoplantar Pustulosis (PPP) Unmet Needs
  10. Key Endpoints of Palmoplantar Pustulosis (PPP) Treatment
  11. Palmoplantar Pustulosis (PPP) Marketed Products
  12. Palmoplantar Pustulosis (PPP) Emerging Therapies
  13. Palmoplantar Pustulosis (PPP) Seven Major Market Analysis
  14. Attribute Analysis
  15. Palmoplantar Pustulosis (PPP) Market Outlook (7 major markets)
  16. Palmoplantar Pustulosis (PPP) Access and Reimbursement Overview
  17. KOL Views on the Palmoplantar Pustulosis (PPP) Market.
  18. Palmoplantar Pustulosis (PPP) Market Drivers
  19. Palmoplantar Pustulosis (PPP) Market Barriers
  20. Appendix
  21. DelveInsight Capabilities
  22. Disclaimer

*The table of contents is not exhaustive; the final content may vary. 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States